Top Tweets for #ZORYVE
🏆 NEWS: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) ZORYVE® (roflumilast) HCP cream 0.15% has received Marie Claire’s inaugural Best Prescription Skin Solution Award ➡️ https://t.co/plJAecKKV6
#Dermatology #AtopicDermatitis #Eczema #ZORYVE #Dermatology

🚨 The FDA has accepted a supplemental New Drug Application from Arcutis to extend the indication for #roflumilast cream 0.3% (#ZORYVE) to include pediatric patients aged 2 to 5 years with plaque #psoriasis.
https://t.co/bUcdFnQe2U #PediatricDerm #PlaquePsoriasis #DermTwitter
🚨 Arcutis Biotherapeutics, Inc. has announced the US commercial launch of #roflumilast cream 0.05% (#Zoryve) for mild to moderate atopic dermatitis in pediatric patients ages 2 to 5 years.
https://t.co/z0oOBWJ0HK #AtopicDerm #PediatricDerm #AD #DermTwitter
🚨 Arcutis has submitted an sNDA to the FDA to expand #roflumilast cream 0.3% (#Zoryve) for the treatment of plaque psoriasis in pediatric patients as young as 2.
https://t.co/IEs7fgCDhr #PediatricDerm #PlaquePsoriasis #Psoriasis #DermTwitter
❗With a new focused update, the American Academy of Dermatology's #AD guidelines now strongly recommend Arcutis' #roflumilast cream 0.15% (#Zoryve) for mild to moderate atopic dermatitis in adults.
https://t.co/xEt3nNVjgm #AAD #AtopicDermatitis #DermTwitter
The FDA has accepted the supplemental new drug application for #Zoryve cream 0.05% to treat mild to moderate #atopic #dermatitis in children aged 2 to 5 years. If approved, this topical will offer a nonsteroidal option children with atopic dermatitis. https://t.co/k0gDXqXflN

Dr Patrick Burnett highlights #roflumilast Cream 0.05% non-steroidal formula, rapid itch relief, and long-term management benefits to treat mild-to-moderate atopic dermatitis in children ages 2-5!
https://t.co/s4LMjS4zPO
#AtopicDermatitis #Dermatology #ZORYVE #FDAUpdate
The #FDA has accepted the supplemental new drug application for #Zoryve cream 0.05% (#roflumilast) to treat mild to moderate #atopic #dermatitis in children aged 2 to 5 years. https://t.co/k0gDXqXflN

Zoryve ® 👀 FDA Approved for Eczema, Psoriasis & Seborrheic Dermatitis 💁🏻♂️The Derm Bros® Discuss 🤜🏻🤛🏻
#LVDerm #Zoryve #skin #eczema #seborrheicdermatitis #LasVegasDermatology #psoriasis #atopicdermatitis #drvegas #dermbros #dermatology #askthedermbros
@lvderm @dermbros @ArcutisBio
The FDA has approved #Roflumilast (ZORYVE) cream 0.15% for treating mild to moderate #AtopicDermatitis in adults and children aged 6 and older.
https://t.co/rmzxTGSeRg
#FDAApproval #EczemaRelief #Dermatology #SkinCare #ClinicalTrials #ZORYVE #ArcutisBiotherapeutics
One would think that the $ARQT PDUFA for #Zoryve for atopic dermatitis would be a slam-dunk, given that it is already approved for other indications, and the study results were very positive.
$ARQT - Company anticipates a letter from FDA. The FDA has not requested any additional information. I have not seen this before. Very strange. https://t.co/8KDajjhknP
#معلومة
حصلت شركة Arcutis Biotherapeutics Inc. على موافقة إدارة الغذاء والدواء الأمريكية (FDA) على دواءها المطور حديثًا #roflumilast
#Zoryve، المصمم لمعالجة التهاب الجلد الدهني (seborrheic dermatitis). Zoryve هو علاج موضعي مخصص ويستهدف السبب الأساسي للحالة. تعتبر موافقة إدارة الغذاء والدواء الأمريكية جديرة بالملاحظة نظرًا للنطاق المحدود من خيارات العلاج المتاحة لالتهاب الجلد الدهني في الوقت الحالي.
والجدير بالملاحظه فان
#Roflumilast اذا كان على شكل اقراص بالفم فهو مرخص لعلاج مرض الانسداد الرئوي المزمن الحاد COPD
اما اذا كان شكله الدوائي موضعي مثل الكريم او الرغوة فهو يستخدم لعلاج الصدفية والتهابات الجلد ويتميز بانه دواء لايحتوي على الكورتيزون

July #FDA approvals tracker: 👍include $ARQT, $ETON $INCY, while still⏰waiting for $AXSM and $AKESF, $SBMFF: https://t.co/JKteQ1h4Mo
#Pdufa #Zoryve #penpulimab #tislelizumab #Opzelura $NVS $BGNE

@AADmember here's what I'll tell my patients about #ZORYVE (#roflumilast) cream: It's used once a day for the treatment of #psoriasis in people 12 years or older. About 39% of patients achieve clear or almost clear skin with ZORYVE (roflumilast) cream after 8 weeks of use.

Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.6M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90.1M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.5M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.5M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers
















